Back
Datadog Vs. Halozyme Therapeutics Industry Stock Comparison
Buy
87
DDOG
Datadog
Last Price:
$149.91
Seasonality Move:
5.98%
Buy
63
HALO
Halozyme Therapeutics
Last Price:
$58.23
Seasonality Move:
-3.74%
Buy
63
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics a Buy, Sell or Hold?
-
The current Halozyme Therapeutics [HALO] share price is $58.24. The Score for HALO is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
HALO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $58.24Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.
DDOG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.25 | Buy |
Relative Strength Index (14 RSI): | 67.74 | Buy |
Chaikin Money Flow: | 3490149 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (132.22 - 147.1) | Buy |
Bollinger Bands (100): | (98.62 - 132.64) | Buy |
HALO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 14.19 | Buy |
Relative Strength Index (14 RSI): | 59.7 | Buy |
Chaikin Money Flow: | -565928 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.16 - 57.74) | Buy |
Bollinger Bands (100): | (53.54 - 62.3) | Buy |
DDOG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 144.76 | Buy |
20-day SMA: | 142.12 | Buy |
50-day SMA: | 129.41 | Buy |
200-day SMA: | 126.71 | Buy |
8-day EMA: | 145.24 | Buy |
20-day EMA: | 140.94 | Buy |
50-day EMA: | 127.84 | Buy |
200-day EMA: | 70.82 | Buy |
HALO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.66 | Buy |
20-day SMA: | 56.1 | Buy |
50-day SMA: | 54.5 | Buy |
200-day SMA: | 55.42 | Buy |
8-day EMA: | 56.11 | Buy |
20-day EMA: | 43.37 | Buy |
50-day EMA: | 24.62 | Buy |
200-day EMA: | 7.49 | Buy |
Datadog Earnings Growth & DDOG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.08 per share, a decrease this year of $0.07 per share, and an increase next year of $0.35 per share.
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.06 per share, an increase this year of $1.27 per share, and an increase next year of $1.48 per share.
Datadog Technical Analysis
Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Halozyme Therapeutics Technical Analysis
Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |